Euromed International Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 04-07-2024
- Paid Up Capital ₹ 0.10 M
as on 04-07-2024
- Company Age 26 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -84.25%
(FY 2022)
- Profit -164.39%
(FY 2022)
- Ebitda -867.10%
(FY 2022)
- Net Worth -5.28%
(FY 2022)
- Total Assets 0.21%
(FY 2022)
About Euromed International
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Navin Sexena, Balasaheb Patil, and Kunal Saxena serve as directors at the Company.
- CIN/LLPIN
U24239MH1998PTC113193
- Company No.
113193
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jan 1998
- Date of AGM
15 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Euromed International?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Navin Sexena  | Director | 23-Jan-1998 | Current |
| Balasaheb Patil | Director | 14-Jul-2006 | Current |
| Kunal Saxena | Director | 19-Apr-2013 | Current |
Financial Performance of Euromed International.
Euromed International Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 84.25% decrease. The company also saw a substantial fall in profitability, with a 164.39% decrease in profit. The company's net worth dipped by a decrease of 5.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Euromed International?
In 2021, Euromed International had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Quantys Clinical Private LimitedActive 10 years 4 monthsNavin Sexena and Kunal Saxena are mutual person
Navin Saxena Research And Technology Private LimitedActive 30 years 28 daysNavin Sexena and Kunal Saxena are mutual person
Navicare Pharma Private LimitedActive 13 years 7 monthsNavin Sexena and Kunal Saxena are mutual person
Rusan Health Care Private LimitedActive 25 years 1 monthNavin Sexena, Balasaheb Patil and 1 more are mutual person
- Rusan Pharma LimitedActive 30 years 9 months
Navin Sexena, Balasaheb Patil and 1 more are mutual person
- Tuscany Holdings Private LimitedActive 30 years 2 months
Navin Sexena and Kunal Saxena are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Euromed International?
Unlock and access historical data on people associated with Euromed International, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Euromed International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Euromed International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
